BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16171004)

  • 1. [Positron emission tomography (PET)--current state of the art and future perspectives].
    von Schulthess GK;
    Praxis (Bern 1994); 2005 Aug; 94(35):1331-7. PubMed ID: 16171004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography/computed tomography.
    Townsend DW
    Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography: current status and future challenges.
    Lin M; Shon IH; Lin P
    Intern Med J; 2010 Jan; 40(1):19-29. PubMed ID: 20561362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning.
    Weber WA; Grosu AL; Czernin J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):160-70. PubMed ID: 18253106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET and PET-CT. State of the art and future prospects.
    Fanti S; Franchi R; Battista G; Monetti N; Canini R
    Radiol Med; 2005; 110(1-2):1-15. PubMed ID: 16163136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical PET/CT imaging: promises and misconceptions.
    Czernin J; Auerbach MA
    Nuklearmedizin; 2005; 44 Suppl 1():S18-23. PubMed ID: 16395974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of PET/CT and clinical application].
    Bockisch A; Beyer T; Antoch G; Veit P; Müller S; Pink R; Rosenbaum S; Kühl H
    Radiologe; 2004 Nov; 44(11):1045-54. PubMed ID: 15517140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT: fundamental principles.
    Seemann MD
    Eur J Med Res; 2004 May; 9(5):241-6. PubMed ID: 15257877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated PET/CT: current applications and future directions.
    von Schulthess GK; Steinert HC; Hany TF
    Radiology; 2006 Feb; 238(2):405-22. PubMed ID: 16436809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac positron emission tomography imaging.
    Machac J
    Semin Nucl Med; 2005 Jan; 35(1):17-36. PubMed ID: 15645392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated PET/CT and cancer imaging.
    De Wever W; Coolen J; Verschakelen JA
    JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
    J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular positron emission tomography and PET/CT imaging in urological malignancies.
    Powles T; Murray I; Brock C; Oliver T; Avril N
    Eur Urol; 2007 Jun; 51(6):1511-20; discussion 1520-1. PubMed ID: 17275167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT in oncology--a major advance.
    Wechalekar K; Sharma B; Cook G
    Clin Radiol; 2005 Nov; 60(11):1143-55. PubMed ID: 16223611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
    Czernin J; Allen-Auerbach M; Schelbert HR
    J Nucl Med; 2007 Jan; 48 Suppl 1():78S-88S. PubMed ID: 17204723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
    Cohade C; Wahl RL
    Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.